Medicare Enrolled
Dr. Rajesh Ailani, M.D.
Critical Care Medicine · New Smyrna Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ailani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ailani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ailani
Dr. Rajesh Ailani is a critical care medicine specialist in New Smyrna Beach, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ailani performed 26,658 Medicare services across 6,545 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ailani received a total of $20,319 from 59 pharmaceutical and/or device companies across 883 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ailani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in FL
$20,319 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 89115 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗26,658
Medicare services
Top 1% in FL for critical care medicine
6,545
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,333 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
12,567 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,777 | $95 | $248 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
1,712 | $0 | $1 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,259 | $94 | $200 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
1,016 | $48 | $128 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
995 | $29 | $74 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
977 | $12 | $30 |
| Injection, levofloxacin, 250 mg | 809 | $1 | $3 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
686 | $42 | $110 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
677 | $40 | $104 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
529 | $11 | $28 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
500 | $63 | $140 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
428 | $9 | $26 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
261 | $121 | $328 |
| Ertapenem sodium injection, 500 mg An injection of ertapenem sodium, an antibiotic medication, administered at a dose of 500 mg. |
232 | $11 | $111 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
172 | $136 | $387 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
153 | $170 | $546 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
107 | $103 | $264 |
| Positive pressure ventilator therapy A therapy procedure that uses a positive pressure ventilator to assist with breathing. |
100 | $48 | $124 |
| Injection, furosemide, up to 20 mg | 93 | $0 | $2 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
83 | $455 | $1,150 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
78 | $68 | $450 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
76 | $477 | $1,202 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
76 | $40 | $106 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
74 | $9 | $24 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
52 | $30 | $36 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
46 | $13 | $33 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
42 | $33 | $66 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
42 | $32 | $82 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
16 | $15 | $30 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
12 | $76 | $144 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
11 | $35 | $126 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.8% high complexity
65.1% medium
31.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$20,319
Total received (2018-2024)
Avg $2,903/year across 7 years
Top 10% in FL for critical care medicine
59
Companies
883
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,623 (67.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,696 (33.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,992
2023
$2,321
2022
$2,390
2021
$2,004
2020
$1,501
2019
$3,152
2018
$6,959
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Allergan Inc.
$5,301
GlaxoSmithKline, LLC.
$2,498
AstraZeneca Pharmaceuticals LP
$2,239
Allergan, Inc.
$1,589
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,168
Grifols USA, LLC
$1,129
Amgen Inc.
$527
JAZZ PHARMACEUTICALS INC.
$466
GENZYME CORPORATION
$418
Philips Electronics North America Corporation
$367
Takeda Pharmaceuticals U.S.A., Inc.
$366
Regeneron Healthcare Solutions, Inc.
$302
bioMerieux
$281
Teva Pharmaceuticals USA, Inc.
$269
Mylan Specialty L.P.
$266
Inspire Medical Systems, Inc.
$265
CSL Behring
$257
Actelion Pharmaceuticals US, Inc.
$226
PFIZER INC.
$180
AbbVie Inc.
$180
Genentech USA, Inc.
$175
Jazz Pharmaceuticals Inc.
$138
Insmed, Inc.
$137
Harmony Biosciences LLC
$122
Electromed, Inc.
$114
ABBVIE INC.
$85
Paratek Pharmaceuticals, Inc.
$83
Merck Sharp & Dohme LLC
$80
SANOFI-AVENTIS U.S. LLC
$80
Merck Sharp & Dohme Corporation
$80
Novartis Pharmaceuticals Corporation
$75
Eisai Inc.
$74
Shire North American Group Inc
$61
NOVARTIS PHARMACEUTICALS CORPORATION
$47
Astellas Pharma US Inc
$42
Nabriva Therapeutics, plc
$37
UCB, Inc.
$37
Melinta Therapeutics, LLC
$37
Mallinckrodt Hospital Products Inc.
$36
Inogen, Inc.
$36
Inari Medical, Inc.
$35
Axsome Therapeutics, Inc.
$33
Baxter Healthcare
$32
EMD Serono, Inc.
$32
Fisher & Paykel Healthcare Inc
$29
La Jolla Pharmaceutical Company
$28
Mallinckrodt LLC
$27
HARMONY BIOSCIENCES LLC
$25
BOSTON SCIENTIFIC CORPORATION
$25
IMPEL PHARMACEUTICALS INC.
$23
Microtransponder, Inc.
$23
Optinose US, Inc.
$22
United Therapeutics Corporation
$22
Vanda Pharmaceuticals Inc.
$20
INOGEN, INC.
$20
Circassia Pharmaceuticals Inc
$13
Breas Medical, Inc.
$13
CHF Solutions, Inc
$13
Veran Medical Technologies, Inc.
$11
Top 3 companies account for 49.4% of total payments
Associated products mentioned in payments ›
(8744) Trilogy Evo · (8874) inCourage · ACTHAR · AIRSUPRA · AJOVY · ALAIR · ANORO · ANORO ELLIPTA · AUSTEDO · AVYCAZ · AirDuo Digihaler · Aquadex · Arikayce · Austedo XR · BELSOMRA · BENLYSTA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · Baxdela · Briviact · CINQAIR · COMBIVENT RESPIMAT · CUVITRU · Cimzia · Cresemba · DALVANCE · DIFICID · DUAKLIR PRESSAIR · DUPIXENT · Dayvigo · Dymista · ELIQUIS · EVUSHELD · Enbrel · Esbriet · FARXIGA · FASENRA · FISHER & PAYKEL HEALTHCARE · FLOWTRIEVER CATHETER · Fycompa · GIAPREZA · GLASSIA · Gamunex-C · HYQVIA · Hillrom - Vest System Model 105 Home Care · Hizentra · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · InogenOne · Leqembi · MEKINIST · MYCAMINE · NUCALA · NUZYRA · OFEV · OPSUMIT · PANZYGA · PONVORY · Prolastin-C · Prolastin-C Liquid · Prolia · Repatha · Respiratoriy Care Undiv · S · SHINGRIX · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · Sunosi · TAVNEOS · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · Trudhesa · UBRELVY · UPTRAVI · VIDAS BRAHMS PCT · Vivo 45 LS · Wakix · Wellcentive Undiv · XERAVA · XOLAIR · XYREM · XYWAV · Xembify · Xenleta · Xhance · Xolair · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (67%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for critical care medicine in FL.
Equivalent to $76 per 100 Medicare services performed
Geographic Context
Critical care medicines within 10 mi
20
Per 100K population
3.5
County median income
$66,581
Nearest hospital
HALIFAX HEALTH MEDICAL CENTER
13.7 mi
13.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ailani is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), with low-engagement industry engagement in the top 10% of FL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ailani experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Ailani performed 12,567 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ailani receive payments from pharmaceutical companies?
Yes. Dr. Ailani received a total of $20,319 from 59 companies across 883 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ailani's costs compare to other critical care medicines in New Smyrna Beach?
Dr. Ailani's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ailani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in New Smyrna Beach
Browse critical care medicines in New Smyrna Beach ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in FL
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in FL
Which FL critical care medicines receive the most from drug and device companies.
By company
Allergan Inc. Payments to Doctors
See all physicians who received payments from Allergan Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology